Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Deficit (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance at Dec. 31, 2022 $ (91,421) $ 14 $ 269,574 $ (361,168) $ 159
Beginning balance, Shares at Dec. 31, 2022   142,503,771      
Net loss (54,445)     (54,445)  
Other comprehensive income (loss), net of tax 20       20
Share-based compensation 10,166   10,166    
Settlement of vested restricted stock units, Shares   1,665,333      
Exercise of stock options 355   355    
Exercise of stock options, Shares   511,119      
Ending balance at Mar. 31, 2023 (135,325) $ 14 280,095 (415,613) 179
Ending balance, Shares at Mar. 31, 2023   144,680,223      
Beginning balance at Dec. 31, 2023 (157,636) $ 20 355,144 (513,011) 211
Beginning balance, Shares at Dec. 31, 2023   199,413,917      
Net loss (53,244)     (53,244)  
Other comprehensive income (loss), net of tax (37)       (37)
Share-based compensation 3,816   3,816    
Settlement of vested restricted stock units, Shares   1,834,805      
Exercise of stock options 21   21    
Exercise of stock options, Shares   30,940      
Ending balance at Mar. 31, 2024 $ (207,080) $ 20 $ 358,981 $ (566,255) $ 174
Ending balance, Shares at Mar. 31, 2024   201,279,662